Details about the neuroanatomical projections from ORBm to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91778 | Orbital area medial part | Ectorhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: the terminal field in PERI extends for a small distance in the ventral ECT, in layers I-III. Few terminals are also seen in layer V. See Fig. 4B, Swanson Atlas Levels 31-33. | Kondo H. & Witter M.P., 2014 | |
| 91780 | Orbital area medial part | Ectorhinal area | light | biotinylated dextran amine (BDA) | Collator note: few terminals in the rostralmost part of the ECT. See Fig. 4A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
| 91782 | Orbital area medial part | Ectorhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeled fibers mostly in layers II-III, mid-rostrocaudally. See Fig. 4C, Swanson Atlas Levels 38-39. | Kondo H. & Witter M.P., 2014 | |
| 91784 | Orbital area medial part | Ectorhinal area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal PERI and ECT. See Fig. 4D, Swanson Atlas Levels 41-42. | Kondo H. & Witter M.P., 2014 | |
| 91787 | Orbital area medial part | Ectorhinal area | light | biotinylated dextran amine (BDA) | Collator note: weak labeling of the caudal ECT. See Fig. 4D-F, Swanson Atlas Levels 43-47. The terminals are shown mostly in layer II, and few in layer V. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Further details associated to record number 91782:
|
|
|---|
